97 related articles for article (PubMed ID: 6790398)
1. [Pathophysiological study on monocrotaline-induced pulmonary hypertension in rats (author's transl].
Kido M
Fukuoka Igaku Zasshi; 1981 Mar; 72(3):117-30. PubMed ID: 6790398
[No Abstract] [Full Text] [Related]
2. [Morphological study of monocrotaline-induced pulmonary hypertension in rats].
Nakashima M
Nihon Kyobu Shikkan Gakkai Zasshi; 1983 Mar; 21(3):227-39. PubMed ID: 6415328
[No Abstract] [Full Text] [Related]
3. [The mechanism of the development of pulmonary hypertension induced by monocrotaline in rats].
Kataoka R; Tobise K
Nihon Kyobu Shikkan Gakkai Zasshi; 1987 May; 25(5):563-73. PubMed ID: 3118089
[No Abstract] [Full Text] [Related]
4. Changes in main pulmonary artery of rats with monocrotaline-induced pulmonary hypertension.
Guzowski DE; Salgado ED
Arch Pathol Lab Med; 1987 Aug; 111(8):741-5. PubMed ID: 3115224
[TBL] [Abstract][Full Text] [Related]
5. [Reduction of the development of monocrotaline-induced pulmonary hypertension in rats by artificial unilateral pneumothorax].
Sugita T; Sawada A; Kuriyama T; Yamagishi F; Kohchi F; Naitoh T; Kakusaka I; Okada O; Watanabe S; Ogata T
Nihon Kyobu Shikkan Gakkai Zasshi; 1985 Nov; 23(11):1328-36. PubMed ID: 3937926
[No Abstract] [Full Text] [Related]
6. [Monocrotaline-induced pulmonary hypertension with special reference to the influence of dose, age, and sex].
Sawada A; Kuriyama T; Sugita T; Watanabe S
Nihon Kyobu Shikkan Gakkai Zasshi; 1985 May; 23(5):578-83. PubMed ID: 3932735
[No Abstract] [Full Text] [Related]
7. [Mast cell hyperplasia in monocrotaline-induced pulmonary changes in rats].
Kuriyama T; Sawada A; Sugita T; Watanabe S; Shen SY; Hiroshima K; Hayashi Y
Nihon Kyobu Shikkan Gakkai Zasshi; 1985 Aug; 23(8):865-72. PubMed ID: 3935842
[No Abstract] [Full Text] [Related]
8. [Experimental pulmonary hypertension--with special reference to physiopathology and etiology of pulmonary hypertension caused by monocrotaline].
Watanabe S
Kokyu To Junkan; 1979 Jan; 27(1):4-11. PubMed ID: 482744
[No Abstract] [Full Text] [Related]
9. Increased alveolar-capillary membrane permeability by monocrotaline.
Kido M; Hirose T; Tanaka K; Kurozumi T; Shoyama Y
Jpn J Med; 1981 Jul; 20(3):170-9. PubMed ID: 6803046
[TBL] [Abstract][Full Text] [Related]
10. [Pulmonary circulatory disturbance due to pulmonary peripheral lesions--etiology of experimental pulmonary hypertension and cor pulmonale].
Watanabe S
Kokyu To Junkan; 1981 May; 29(5):481-5. PubMed ID: 6797009
[No Abstract] [Full Text] [Related]
11. Tetrandrine inhibited chronic "inflammatory" pulmonary hypertension in rats.
Wang HL; Zhang XH; Jin X; Xing J; Zhang DR
Zhongguo Yao Li Xue Bao; 1997 Sep; 18(5):401-4. PubMed ID: 10322926
[TBL] [Abstract][Full Text] [Related]
12. [Effect of hydralazine on the pulmonary arterial hypertension in monocrotaline induced cor pulmonale in Macacus rhesus].
Sun BT
Zhonghua Jie He He Hu Xi Za Zhi; 1987 Aug; 10(4):229-30, 255, 15. PubMed ID: 3125990
[No Abstract] [Full Text] [Related]
13. Endocardial fibrosis associated with monocrotaline-induced pulmonary hypertension in nonhuman primates (Macaca arctoides).
Chesney CF; Allen JR
Am J Vet Res; 1973 Dec; 34(12):1577-81. PubMed ID: 4271643
[No Abstract] [Full Text] [Related]
14. Preventive effects of raloxifene, a selective estrogen receptor modulator, on monocrotaline-induced pulmonary hypertension in intact and ovariectomized female rats.
Nishida M; Hasegawa Y; Tanida I; Nakagawa E; Inaji H; Ohkita M; Matsumura Y
Eur J Pharmacol; 2009 Jul; 614(1-3):70-6. PubMed ID: 19379725
[TBL] [Abstract][Full Text] [Related]
15. [Metabolism of vasoactive substances and pulmonary hypertension (author's transl)].
Kuriyama T; Sugita T; Watanabe S; Ogata T
Nihon Kyobu Shikkan Gakkai Zasshi; 1978 Jun; 16(6):418-24. PubMed ID: 212629
[No Abstract] [Full Text] [Related]
16. Primary pulmonary hypertension, a review.
Widimský J
Cor Vasa; 1982; 24(5):309-17. PubMed ID: 6816507
[No Abstract] [Full Text] [Related]
17. Abnormal alveolar cells in monocrotaline induced pulmonary hypertension.
Sugita T; Stenmark KR; Wagner WW; Henson PM; Henson JE; Hyers TM; Reeves JT
Exp Lung Res; 1983 Nov; 5(3):201-15. PubMed ID: 6418536
[TBL] [Abstract][Full Text] [Related]
18. [Preventive effects of tetrandrine on pulmonary hypertension and right ventricular hypertrophy in rats induced by monocrotaline].
Jin X; Zhang X; Xing J; Liu K; Wang H
Zhongguo Zhong Yao Za Zhi; 1996 Dec; 21(12):751-2, 763. PubMed ID: 9812685
[TBL] [Abstract][Full Text] [Related]
19. Oral sildenafil prevents and reverses the development of pulmonary hypertension in monocrotaline-treated rats.
Liu H; Liu ZY; Guan Q
Interact Cardiovasc Thorac Surg; 2007 Oct; 6(5):608-13. PubMed ID: 17670742
[TBL] [Abstract][Full Text] [Related]
20. Monocrotaline-induced pulmonary vascular disease after contralateral lung transplantation in the rat.
Kawaguchi AT; Kawashima Y; Ishibashi-Ueda H; Mizuta T; Kitoh Y; Kunieda T
J Heart Lung Transplant; 1993; 12(2):325-8; discussion 328-9. PubMed ID: 8476905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
